249 related articles for article (PubMed ID: 31053545)
21. Top-ranking drugs out of 3312 drug-induced liver injury cases evaluated by the Roussel Uclaf Causality Assessment Method.
Teschke R
Expert Opin Drug Metab Toxicol; 2018 Nov; 14(11):1169-1187. PubMed ID: 30354694
[TBL] [Abstract][Full Text] [Related]
22. A prospective study of the incidence of drug-induced liver injury by the modern volatile anaesthetics sevoflurane and desflurane.
Bishop B; Hannah N; Doyle A; Amico F; Hockey B; Moore D; Sood S; Gorelik A; Liew D; Njoku D; Nicoll A
Aliment Pharmacol Ther; 2019 Apr; 49(7):940-951. PubMed ID: 30761577
[TBL] [Abstract][Full Text] [Related]
23. Agreement Among Different Scales for Causality Assessment in Drug-Induced Liver Injury.
Das S; Behera SK; Xavier AS; Velupula S; Dkhar SA; Selvarajan S
Clin Drug Investig; 2018 Mar; 38(3):211-218. PubMed ID: 29185238
[TBL] [Abstract][Full Text] [Related]
24. Drug-induced liver injury: A 2-year retrospective study of 1169 hospitalized patients in a single medical center.
Woo HJ; Kim HY; Choi ES; Cho YH; Kim Y; Lee JH; Jang E
Phytomedicine; 2015 Dec; 22(13):1201-5. PubMed ID: 26598920
[TBL] [Abstract][Full Text] [Related]
25. A prospective nationwide study of drug-induced liver injury in Korea.
Suk KT; Kim DJ; Kim CH; Park SH; Yoon JH; Kim YS; Baik GH; Kim JB; Kweon YO; Kim BI; Kim SH; Kim IH; Kim JH; Nam SW; Paik YH; Suh JI; Sohn JH; Ahn BM; Um SH; Lee HJ; Cho M; Jang MK; Choi SK; Hwang SG; Sung HT; Choi JY; Han KH
Am J Gastroenterol; 2012 Sep; 107(9):1380-7. PubMed ID: 22733303
[TBL] [Abstract][Full Text] [Related]
26. Presentations, Causes and Outcomes of Drug-Induced Liver Injury in Egypt.
Alhaddad O; Elsabaawy M; Abdelsameea E; Abdallah A; Shabaan A; Ehsan N; Elrefaey A; Elsabaawy D; Salama M
Sci Rep; 2020 Mar; 10(1):5124. PubMed ID: 32198411
[TBL] [Abstract][Full Text] [Related]
27. In silico modeling to optimize interpretation of liver safety biomarkers in clinical trials.
Church RJ; Watkins PB
Exp Biol Med (Maywood); 2018 Feb; 243(3):300-307. PubMed ID: 29096561
[TBL] [Abstract][Full Text] [Related]
28. Liver injury from nonsteroidal anti-inflammatory drugs in the United States.
Schmeltzer PA; Kosinski AS; Kleiner DE; Hoofnagle JH; Stolz A; Fontana RJ; Russo MW;
Liver Int; 2016 Apr; 36(4):603-9. PubMed ID: 26601797
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of Drug- and Herb-Induced Liver Injury Assessed for Causality Using the Updated RUCAM in Two Hospitals from China.
Chen Y; Wang C; Yang H; Huang P; Shi J; Tong Y; Jiang J; Zhang X; Chen W; Xuan Z
Biomed Res Int; 2021; 2021():8894498. PubMed ID: 33954202
[TBL] [Abstract][Full Text] [Related]
30. Monocyte-derived hepatocyte-like cells for causality assessment of idiosyncratic drug-induced liver injury.
Benesic A; Leitl A; Gerbes AL
Gut; 2016 Sep; 65(9):1555-63. PubMed ID: 26045135
[TBL] [Abstract][Full Text] [Related]
31. Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment.
Mullins C; Beaulac K; Sylvia L
Ann Pharmacother; 2020 Jun; 54(6):526-532. PubMed ID: 31786964
[No Abstract] [Full Text] [Related]
32. Drug-induced hepatotoxicity: incidence of abnormal liver function tests consistent with volatile anaesthetic hepatitis in trauma patients.
Lin J; Moore D; Hockey B; Di Lernia R; Gorelik A; Liew D; Nicoll A
Liver Int; 2014 Apr; 34(4):576-82. PubMed ID: 23944929
[TBL] [Abstract][Full Text] [Related]
33. Causality assessment of herb-induced liver injury using multidisciplinary approach and Roussel Uclaf Causality Assessment Method (RUCAM).
Nin Chau T; Cheung WI; Ngan T; Lin J; Lee KW; Tat Poon W; Leung VK; Mak T; Tse ML;
Clin Toxicol (Phila); 2011 Jan; 49(1):34-9. PubMed ID: 21114414
[TBL] [Abstract][Full Text] [Related]
34. A detection algorithm for drug-induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale.
Hanatani T; Sai K; Tohkin M; Segawa K; Kimura M; Hori K; Kawakami J; Saito Y
Pharmacoepidemiol Drug Saf; 2014 Sep; 23(9):984-8. PubMed ID: 24596340
[TBL] [Abstract][Full Text] [Related]
35. Alanine transaminase and hemoglobin appear to predict the occurrence of antituberculosis medication hepatotoxicity; findings and implications in Botswana.
Kesenogile B; Godman B; Rwegerera GM
Expert Rev Anti Infect Ther; 2021 Mar; 19(3):379-391. PubMed ID: 32909487
[TBL] [Abstract][Full Text] [Related]
36. Drug Hepatotoxicity: Causality Assessment.
Caines A; Moonka D
Clin Liver Dis; 2020 Feb; 24(1):25-35. PubMed ID: 31753248
[TBL] [Abstract][Full Text] [Related]
37. [Hepatotoxicity associated with the use of Herbalife].
Jóhannsson M; Ormarsdóttir S; Olafsson S
Laeknabladid; 2010 Mar; 96(3):167-72. PubMed ID: 20197595
[TBL] [Abstract][Full Text] [Related]
38. An analysis of silybin meglumine tablets in the treatment of drug-induced liver injury as assessed for causality with the updated Roussel Uclaf Causality Assessment Method using a nationwide database.
Zhang B; Jiang G; Wang L; Li X; Zhao C; Tan Q; Kang W; Feng Y; Han X; Raza HK; Mao Y
Br J Clin Pharmacol; 2023 Apr; 89(4):1329-1337. PubMed ID: 36278948
[TBL] [Abstract][Full Text] [Related]
39. Utility of Lymphocyte Transformation Test for Assisting Updated Roussel Uclaf Causality Assessment Method in Drug-Induced Liver Injury: A Case-Control Study.
Rodríguez A; García-García I; Martínez de Soto L; Gómez López De Las Huertas A; Borobia AM; González-Torbay A; Akatbach-Bousaid I; González-Muñoz M; Ramírez E
Front Pharmacol; 2022; 13():819589. PubMed ID: 35370653
[No Abstract] [Full Text] [Related]
40. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method.
Rockey DC; Seeff LB; Rochon J; Freston J; Chalasani N; Bonacini M; Fontana RJ; Hayashi PH;
Hepatology; 2010 Jun; 51(6):2117-26. PubMed ID: 20512999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
